Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Non-Current Assets (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Non-Current Assets for 10 consecutive years, with $441462.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 20.67% to $441462.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.0 million, a 8.3% increase, with the full-year FY2024 number at $533840.0, up 20.16% from a year prior.
  • Non-Current Assets was $441462.0 for Q3 2025 at Creative Medical Technology Holdings, down from $472521.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $596742.0 in Q1 2021 to a low of $385750.0 in Q2 2024.
  • A 5-year average of $483166.6 and a median of $472521.0 in 2025 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: skyrocketed 43.32% in 2021, then decreased 20.67% in 2025.
  • Creative Medical Technology Holdings' Non-Current Assets stood at $530960.0 in 2021, then decreased by 17.34% to $438876.0 in 2022, then rose by 1.23% to $444292.0 in 2023, then increased by 20.16% to $533840.0 in 2024, then fell by 17.3% to $441462.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Non-Current Assets are $441462.0 (Q3 2025), $472521.0 (Q2 2025), and $503263.0 (Q1 2025).